Thursday, November 17, 2016

UPDATE 1-No early win for Sanofi, Regeneron cholesterol drug in study

Nov 17 (Reuters) - Sanofi and Regeneron

Pharmaceuticals said on Thursday they would continue a

large clinical outcomes study with their injectable

cholesterol-lowering drug Praluent, confounding...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)